{
  "id": 12189040,
  "title": "FDA delays Novo’s hemophilia A drug review over factory issues",
  "url": "https://urgent.news/2026/10/05/fda-delays-novos-hemophilia-a-drug-review-over-factory-issues",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-05T16:27:02.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/fda-delays-novos-hemophilia-a-drug-review-over-factory-issues/"
  },
  "original_language": "en",
  "account": null,
  "summary": "US regulators have extended their review of Novo's hemophilia A injection, denecimig, because of issues at an unnamed manufacturing facility. The FDA attributed the delay to “ongoing facility remediation activities” observed during a pre-license inspection ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}